b'<div class="" id="tab-opinion">\n<ul class="tab-nav list-inline-block -pipe-medium-tablet list-no-styles has-no-padding">\n<li class="nav-item tab-item-selected ">\n<a class="highlight" data-equivalent="link-opinion-1954052" data-go-to="tab-1" href="#tab-opinion-1954052" id="list-opinion-1954052">Syllabus</a>\n</li>\n<li class="nav-item">\n<a class="highlight" data-equivalent="link-opinion-1954053" data-go-to="tab-1" href="#tab-opinion-1954053" id="list-opinion-1954053">Case</a>\n</li>\n</ul>\n<div class="" id="tab-opinion-1954052">\n<div class="-display-inline-block text-left">\n<span class="headertext"><h2>U.S. Supreme Court </h2><h3> STAATS, v. BRISTOL LABORATORIES, 451 U.S. 400 (1981) </h3><b><b>451 U.S. 400</b></b><p><b> STAATS, COMPTROLLER GENERAL OF THE UNITED STATES, ET AL. v. BRISTOL <br/> LABORATORIES DIVISION OF BRISTOL-MYERS CO. <br/> CERTIORARI TO THE UNITED STATES COURT OF APPEALS FOR THE SECOND CIRCUIT. <br/>No. 80-264.<br/> <br/>Argued March 24, 1981. <br/>Decided April 29, 1981.<br/></b></p><p> </p><p> <a class="appeallink" href="http://cases.justia.com/us-court-of-appeals/F2/620/17/">620 F.2d 17</a>, affirmed by an equally divided Court.</p><p> Mark I. Levy argued the cause for petitioners. With him on the briefs were Solicitor General McCree, Acting Assistant Attorney General Martin, Deputy Solicitor General Geller, Michael Kimmel, Robert Kaplan, and Milton J. Socolar.</p><p> Gilbert H. Weil argued the cause for respondent. With him on the brief was Robert L. Sherman.<a href="#F*" name="T*">*</a></p><p> </p><p> [<a href="#T*" name="F*">Footnote *</a>] Philip Lacovara, Ronald A. Stern, Stanley L. Temko, Charles Lister, and Clare Dalton filed a brief for Merck &amp; Co., Inc., et al. as amici curiae urging affirmance.</p><p> </p><p> PER CURIAM.</p><p> </p><p> The judgment is affirmed by an equally divided Court.</p><p> JUSTICE STEWART took no part in the consideration or decision of this case. </p><p><a class="page-number" name="401">Page 451 U.S. 400, 401</a></p><p></p><p> <br/><br/><br/>\n</p></span></div>\n</div>\n<div class="hidden-content" id="tab-opinion-1954053">\n<div class="-display-inline-block text-left">\n<span class="headertext"><h2>U.S. Supreme Court </h2><h3> STAATS, v. BRISTOL LABORATORIES, 451 U.S. 400 (1981) </h3><b><b>451 U.S. 400</b></b><p><b> STAATS, COMPTROLLER GENERAL OF THE UNITED STATES, ET AL. v. BRISTOL <br/> LABORATORIES DIVISION OF BRISTOL-MYERS CO. <br/> CERTIORARI TO THE UNITED STATES COURT OF APPEALS FOR THE SECOND CIRCUIT. <br/>No. 80-264.<br/> <br/>Argued March 24, 1981. <br/>Decided April 29, 1981.<br/></b></p><p> </p><p> <a class="appeallink" href="http://cases.justia.com/us-court-of-appeals/F2/620/17/">620 F.2d 17</a>, affirmed by an equally divided Court.</p><p> Mark I. Levy argued the cause for petitioners. With him on the briefs were Solicitor General McCree, Acting Assistant Attorney General Martin, Deputy Solicitor General Geller, Michael Kimmel, Robert Kaplan, and Milton J. Socolar.</p><p> Gilbert H. Weil argued the cause for respondent. With him on the brief was Robert L. Sherman.<a href="#F*" name="T*">*</a></p><p> </p><p> [<a href="#T*" name="F*">Footnote *</a>] Philip Lacovara, Ronald A. Stern, Stanley L. Temko, Charles Lister, and Clare Dalton filed a brief for Merck &amp; Co., Inc., et al. as amici curiae urging affirmance.</p><p> </p><p> PER CURIAM.</p><p> </p><p> The judgment is affirmed by an equally divided Court.</p><p> JUSTICE STEWART took no part in the consideration or decision of this case. </p><p><a class="page-number" name="401">Page 451 U.S. 400, 401</a></p><p></p><p>\n</p></span></div>\n</div>\n</div>'